Indirect comparisons: the mesh and mess of clinical trials. (Q51929967)

17 April 2018

title

Indirect comparisons: the mesh and mess of clinical trials. (English)

1 reference

17 April 2018

John P A Ioannidis

1 reference

17 April 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

17 April 2018

published in

The Lancet

1 reference

17 April 2018

volume

368

1 reference

17 April 2018

issue

9546

1 reference

17 April 2018

page(s)

1470-1472

1 reference

17 April 2018

Indirect comparisons of competing interventions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Antibiotics for acute pyelonephritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Network meta-analysis for indirect treatment comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

Better reporting of harms in randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969615-3

7 January 2021

10.1016/S0140-6736(06)69615-3

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018